News

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
By Sriparna Roy and Abigail Summerville (Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the ...
Kenvue has five brands that generate over $1 billion in sales—Johnson’s, Neutrogena, Listerine, Tylenol, and Aveeno—as well as a number of brands that generate over $400 million in sales: Nicorette, ...
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new ...
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...
Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...
Echoing this, short-term traders are also sporting a call-bias. This is per the security's Schaeffer's put/call open interest ...